Why Teva Pharmaceutical Industries (TEVA) stock fell 8.8% on Nov 19, 2026
Teva Pharmaceutical Industries fell 8.8%. Yahoo reported: “Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company” (5:00 pm ET on Nov 18, 2026). Teva Pharmaceutical Industries also filed an 8-K reporting changes to its directors or officers with the SEC after the Nov 18 close. SPY fell 2.0% and its sector ETF, XLV, fell 2.0%.
The move
TEVA closed down 8.8%.
| Reading (ET) | Change | SPY | Sector ETF |
|---|---|---|---|
| Close · 4:00 pm | -8.8% | -2.0% | XLV -2.0% |
Sources
- Yahoo, 5:00 pm ET on Nov 18, 2026: “Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company”
- 8-K (Items 5.02, 7.01, 9.01): filed with the SEC after the Nov 18 close.
Valuation before and after
In the weekly snapshot of Nov 16, 2026, TEVA had a Blended P/E of 20.7 against a Normal P/E of 9.3. As of Nov 19, 2026, its Blended P/E is 17.9 against a Normal P/E of 9.3.
Context
Earlier moves in TEVA
This is the first move we have recorded for TEVA.
What happened next
- We add the 5-session move on Nov 30, 2026 and the 20-session move on Dec 21, 2026.
The question
Why did Teva Pharmaceutical Industries (TEVA) stock fall 8.8% on Nov 19, 2026?
Teva Pharmaceutical Industries fell 8.8%. Yahoo reported: “Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company” (5:00 pm ET on Nov 18, 2026). Teva Pharmaceutical Industries also filed an 8-K reporting changes to its directors or officers with the SEC after the Nov 18 close. SPY fell 2.0% and its sector ETF, XLV, fell 2.0%.